Patents by Inventor Elisabet De Ramon Amat

Elisabet De Ramon Amat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolidinedione derivatives as antidiabetic agents
    Patent number: 7001910
    Abstract: The present invention refers to compounds of the general formula (I), to their possible pharmaceutically acceptable salts and tautomeric forms. The present invention also refers to a process for their production and to their use as antidiabetic and *hypoglycemic agents, alone or in combination with other antidiabetic agents, such as sulfonilureas or biguanides, as well as for the treatment of complications associated to the resistance to the insulin, such as hypertension, hyperuricemia or other cardiovascular, metabolic, endocrine conditions, or other conditions related with diabetes.
    Type: Grant
    Filed: November 15, 2000
    Date of Patent: February 21, 2006
    Assignee: Vita-Invest S.A.
    Inventors: Marisabel Mourelle Mancini, Juan Carlos Del Castillo Nieto, Elisabet De Ramon Amat
  • Esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
    Patent number: 6894076
    Abstract: New esters derived from (RR, SS)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl 2-hydroxybenzoate, analog to Tramadol, a process for obtaining them and the use of these compounds for the production of a medicament with analgesic properties. These new products of general formula (I) exhibit an analgesic activity higher than that of tramadol.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: May 17, 2005
    Assignee: Vita-Invest, S.A.
    Inventors: Marisabel Mourelle Mancini, Elisabet De Ramon Amat, Juan Huguet Clotet
  • Salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
    Publication number: 20040106632
    Abstract: This invention relates to a new salt of 5-(4-{2-′(6-methoxy-pyrimidin-4-yl)methyl-amino!-ethoxy}-benzyl)-thiazolidin-2,4-dione and its polymorphs which has high hypoglycemiant activity and which are therefore potentially useful in the treatment and/or prophylaxis of diabetes and/or other alterations or complications inherent to diabetes, such as hyyperglycemia or hyperlipidemia. This invention also relates to a method for making thereof.
    Type: Application
    Filed: January 9, 2004
    Publication date: June 3, 2004
    Inventors: Juan Carlos Del Castillo Nieto, Francisco Marquillas Olondriz, Elisabet De Ramon Amat
  • Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
    Publication number: 20030100598
    Abstract: New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new compounds of general formula (I) have a higher analgesic activity, a lower toxicity and a longer effective time period than Tramadol.
    Type: Application
    Filed: June 27, 2002
    Publication date: May 29, 2003
    Inventors: Marisabel Mourelle Mancini, Elisabet De Ramon Amat, Juan Huguet Clotet
  • Esters derived from substituted phennyl-cyclohexyl compounds
    Patent number: 6455585
    Abstract: New esters derived from substituted phenyl-cyclohexyl compounds, which are derived from Tramadol, process for obtaining them and their use for preparing a drug with analgesic properties. These new compounds of general formula (I) have a higher analgesic activity, a lower toxicity and a longer effective time period than Tramadol.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: September 24, 2002
    Assignee: Vita Invest, S.A.
    Inventors: Juan Carlos Del Castillo Nieto, Joan Huguet Clotet, Elisabet De Ramon Amat, Maria Chalaux Freixa, Marisabel Mourelle Mancini